Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma
European Institute of Oncology
European Institute of Oncology
National Taiwan University Hospital
University of Chile
The University of Queensland
Odense University Hospital
Medical University of Vienna
Federico II University
University of Kansas Medical Center
Maastricht University Medical Center
Maastricht University Medical Center
Maastricht University Medical Center
Herlev Hospital
Centre Hospitalier Universitaire de Nice
University Hospital Rijeka
Bispebjerg Hospital
M.D. Anderson Cancer Center
University of California, Davis
Universidade do Porto
Institute of Oncology Ljubljana
Assistance Publique - Hôpitaux de Paris
Peter MacCallum Cancer Centre, Australia
University of Aleppo
Global Healthy Living Foundation
Leiden University Medical Center
University Hospital, Basel, Switzerland
Helsinki University Central Hospital
The Netherlands Cancer Institute
Andalusian Network for Design and Translation of Advanced Therapies
Universitair Ziekenhuis Brussel
Massachusetts General Hospital
University of Utah
Karolinska University Hospital
Keio University
Massachusetts General Hospital
Centre Hospitalier Universitaire Vaudois
Peking Union Medical College Hospital
Melanoma Institute Australia
Cedars-Sinai Medical Center
The Christie NHS Foundation Trust
Maastricht University Medical Center
Central Hospital, Nancy, France
BGI, China
Tampere University Hospital
The Netherlands Cancer Institute
Fudan University
Peking University Cancer Hospital & Institute
Regina Elena Cancer Institute
Oslo University Hospital
Fudan University
University Health Network, Toronto